Estimated projection of incidence and mortality of alcohol-related liver disease in China from 2022 to 2040: a modeling study

[1]  Tae Hyun Kim,et al.  Alcohol-Related Liver Disease: An Overview on Pathophysiology, Diagnosis and Therapeutic Perspectives , 2022, Biomedicines.

[2]  A. Dhanda,et al.  Alcohol misuse in patients with alcohol‐related liver disease: How can we do better? A narrative review of the literature , 2022, Alcoholism, clinical and experimental research.

[3]  J. Marrero,et al.  Risk factors for HCC in contemporary cohorts of patients with cirrhosis , 2022, Hepatology.

[4]  I. Soerjomataram,et al.  Modelling the impact of increased alcohol taxation on alcohol-attributable cancers in the WHO European Region , 2021, The Lancet regional health. Europe.

[5]  H. Brenner,et al.  Impact of reducing alcohol consumption through price-based policies on cancer incidence in Germany 2020 to 2050 - a simulation study. , 2020, Addiction.

[6]  Eun Sug Park,et al.  Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 , 2020, Lancet.

[7]  T. Ayer,et al.  Projected prevalence and mortality associated with alcohol-related liver disease in the USA, 2019-40: a modelling study. , 2020, The Lancet. Public health.

[8]  M. Thiele,et al.  Cost‐Effectiveness of Noninvasive Screening for Alcohol‐Related Liver Fibrosis , 2020, Hepatology.

[9]  Yu-nan Xue.  Smoking cessation programmes in China , 2020, The Lancet.

[10]  D. Sridhar,et al.  Metric partnerships: global burden of disease estimates within the World Bank, the World Health Organisation and the Institute for Health Metrics and Evaluation , 2020, Wellcome Open Research.

[11]  T. H. Nguyen,et al.  The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 , 2020, The lancet. Gastroenterology & hepatology.

[12]  Wenjun Wang,et al.  Growing burden of alcoholic liver disease in China: A review , 2019, World journal of gastroenterology.

[13]  Virág Márk.  Cikkismertetés: Globális helyzetjelentés az alkoholról és egészségről 2018 [Article review: Global status report on alcohol and health 2018] , 2019 .

[14]  P. Nahon,et al.  Hepatocellular carcinoma in the setting of alcohol-related liver disease. , 2019, Journal of hepatology.

[15]  You-Ming Li,et al.  Guidelines of prevention and treatment for alcoholic liver disease (2018, China) , 2018, Journal of digestive diseases.

[16]  R. Fontana,et al.  Misconceptions, preferences and barriers to alcohol use disorder treatment in alcohol-related cirrhosis. , 2018, Journal of substance abuse treatment.

[17]  R. Bataller,et al.  Clinical Guideline : Alcoholic Liver Disease , 2018 .

[18]  E. Tsochatzis,et al.  Gender differences in liver disease and the drug‐dose gender gap , 2017, Pharmacological research.

[19]  Shengrong Shen,et al.  Dietary Guidelines for Chinese Residents (2016): comments and comparisons , 2016, Journal of Zhejiang University-SCIENCE B.

[20]  Q. Guo,et al.  [Status of alcohol drinking among population aged 15 and above in China in 2010-2012]. , 2016, Wei sheng yan jiu = Journal of hygiene research.

[21]  R. Bataller,et al.  Pathogenesis and Management of Alcoholic Liver Disease , 2016, Digestive Diseases.

[22]  W. Hao,et al.  Alcohol and related health issues in China: action needed. , 2015, The Lancet. Global health.

[23]  Zheng Zhang,et al.  The global burden of liver disease: The major impact of China , 2014, Hepatology.

[24]  J. Koplan,et al.  Can China diminish its burden of non-communicable diseases and injuries by promoting health in its policies, practices, and incentives? , 2014, The Lancet.

[25]  Haixia Wang,et al.  Prevalence of alcoholic liver disease and its association with socioeconomic status in north-eastern China. , 2014, Alcoholism, clinical and experimental research.

[26]  R. Sanson-Fisher,et al.  The Effectiveness of Community Action in Reducing Risky Alcohol Consumption and Harm: A Cluster Randomised Controlled Trial , 2014, PLoS medicine.

[27]  Wei Hao,et al.  Alcohol and alcohol-related harm in China: policy changes needed. , 2013, Bulletin of the World Health Organization.

[28]  M. Petticrew,et al.  A systematic review of the influence on alcohol use of community level availability and marketing of alcohol. , 2012, Health & place.

[29]  Zhu Rongji,et al.  The State Council of the People's Republic of China Order No. 321 , 2011 .

[30]  Martin McKee,et al.  Priority actions for the non-communicable disease crisis , 2011, The Lancet.

[31]  H. Sørensen,et al.  Clinical course of alcoholic liver cirrhosis: A Danish population‐based cohort study , 2010, Hepatology.

[32]  Xiaohua Yu,et al.  Interactions between cigarette and alcohol consumption in rural China , 2009, The European Journal of Health Economics.

[33]  M. Manns,et al.  A comparison of fibrosis progression in chronic liver diseases. , 2003, Journal of hepatology.

[34]  F. Bray,et al.  Practical implications of imposing a new world standard population , 2002, Cancer Causes & Control.

[35]  A. Parant.  [World population prospects]. , 1990, Futuribles.

[36]  C. Dolea,et al.  World Health Organization , 1949, International Organization.

[37]  [Guidelines of prevention and treatment for alcoholic liver disease: a 2018 update]. , 2018, Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology.

[38]  R. Brůha,et al.  Alcoholic liver disease. , 2012, World journal of hepatology.

[39]  Hu Xiaoqi,et al.  The prevalence of heavy drinking among adults in China. , 2009 .